ЗАСТОСУВАННЯ Α-ГЛІЦЕРИЛФОСФОРИЛХОЛІНУ В СХЕМІ КОМПЛЕКСНОГО ЛІКУВАННЯ ДЛЯ ФУНКЦІОНАЛЬНОГО ВІДНОВЛЕННЯ ПІСЛЯ МОЗКОВОГО ПІВКУЛЬОВОГО ІШЕМІЧНОГО ІНСУЛЬТУ

  • О.О. Пушко Poltava State Medical University, Poltava, Ukraine
  • Н.В. Литвиненко Poltava State Medical University, Poltava, Ukraine
Keywords: ischemic stroke, post-stroke deficit, motor disorders, cognitive disorders, psychoemotional disorders, α-glycerylphosphorylcholine, functional recovery, neurorehabilitation.

Abstract

The article considers the influence of α-glycerylphosphorylcholine in the scheme of comprehensive therapy on the dynamics of functional recovery in patients with cerebral hemispheric ischemic stroke. Against the background of the progressive growth of acute cerebral infarction, the problem of timely care is relevant. Timely treatment of stroke, based on evidence-based medicine, along with early activation and rehabilitation of patients is designed to reduce mortality and subsequent disability of patients. Given that cholinergic insufficiency and structural and functional damage of neurons play an important role in the pathogenesis of post-stroke disorders, the use of medicines for their correction, in particular α-glycerylphosphorylcholine, is justified. Choline alfoscerate, a precursor of acetylcholine and phosphatidylcholine, is broken down by enzymes into choline and glycerophosphate when ingested, and the choline thus obtained is able to improve neuronal functionality in patients with neurodegenerative and vascular diseases. The study revealed a significantly better recovery of impaired motor and cognitive functions after cerebral hemispheric stroke under the influence of comprehensive therapeutic and rehabilitation measures using active rehabilitation methods in conjunction with α-glycerylphosphorylcholine. The results obtained during the study allow us to report the advantage of a combination of methods of active rehabilitation and the use of the pharmacological agent α-glycerylphosphorylcholine. The feasibility and efficacy of α-glycerylphosphorylcholine are related to its ability to reduce motor and cognitive deficits after ischemic stroke. The scheme of comprehensive treatment of patients in acute and restorative periods of cerebral hemispheric ischemic stroke with the use of α-glycerylphosphorylcholine helps to increase the effectiveness of functional recovery after an acute cerebral accident, and can be used in the use of therapeutic and rehabilitation programs for patients after cerebral hemispheric ischemic stroke to reduce the post-stroke deficit.

Downloads

Download data is not yet available.

References

1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020; 141(9):e139–e596. DOI: 10.1161/CIR.0000000000000757
2. Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action Plan for Stroke in Europe 2018–2030. European Stroke Journal. 2018; 3(4):309-336. DOI: 10.1177/2396987318808719
3. Ministerstvo okhorony zdorovia Ukrainy. Unifikovanyi klinichnyi protokol medychnoi dopomohy «Ishemichnyi insult (ekstrena, pervynna, vtorynna (spetsializovana) medychnadopomoha, medychnareabilitatsiia) [Internet]. 2012. Nakaz №602. 2012 serpen 03. Available from: https://dec.gov.ua/wp-content/uploads/images/dodatki/2012_602/2012_602dod4ykpmd.pdf. [Ukrainian]
4. Polishchuk ME, Shchehlov DV, Goncharuk OM, Mamonova MYu, Konotopchyk SV. Suchasnyi stan ta perspektyvy likuvannia insultiv v Ukraini. Endovaskuliarna neirorenthenokhirurhiia. 2017;4(22):14-22. DOI 10.26683/2304-9359-2017-4(22)-14-22. [Ukrainian]
5. Pushko OO, Lytvynenko NV. Peculiarities of neurocognitive status of patients in the acute ischemic stroke phase of different hemispheric localization. World of Medicine and Biology. 2020; 2(72):99-103. DOI 10.26724/2079-8334-2020-2-72-99-103
6. Katan M, Luft A. Global burden of stroke. Seminars in Neurology. 2018; 38(02):208-11. DOI: 10.1055/s-0038-1649503
7. Onishchenko LS, Gaikova ON, Yanishevskii SN. Changes at the focus of experimental ischemic stroke treated with neuroprotective agents. Neuroscience and behavioral physiology. 2008; 38(1):49-54. DOI: 10.1007/s11055-008-0007-1
8. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019; 50:e344-e418. DOI: 10.1161/STR.0000000000000211
9. European Physical and Rehabilitation Medicine Bodies Alliance. White Book on Physical and Rehabilitation Medicine in Europe. European Journal of Physical and Rehabilitation Medicine. 2018; 54(2):125-321. DOI: 10.23736/S1973-9087.18.05143-2
10. Mishchenko VN. Medotilin v lechenii postinsultnykh kognitivnykh narusheniy. Mezhdunarodnyy nevrologicheskiy zhurnal. 2017; 3(89):45-51. DOI: 10.22141/2224-0713.3.89.2017.104242 [Russian]
11. Marcus L, Soileau J, Judge L, Bellar D. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. Journal of the International Society of Sports Nutrition. 2017; 14:39. DOI: 10.1186/s12970-017-0196-5
12. Tayebati SK, Marucci G, Santinelli C, Buccioni M, Amenta F. Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. Current Medicinal Chemistry. 2015; 22(38):4328–4340. DOI: 10.2174/0929867322666151029104152
13. Gallelli L. Choline alphoscerate pharmacology and its role in the treatment of cognitive impairment related to neurological disorders. Functional Neurology. 2011; 26(S1):1-7.
14. Rachin AP. Vygovskaya SN. Nuvakhova MB. Doroginina AYu. Khronicheskaya ishemiya golovnogo mozga – ot pravilnoy diagnostiki k adekvatnoy terapii. Russkiy meditsinskiy zhurnal. 2015; 12:694–698. [Russian]
15. Chernii TV, Fokina DO, Chernii VI. Kompleksne likuvannia khvorykh z khronichnoiu ishemiieiu mozku. tsilespriamovana korektsiia kohnityvnykh porushen ta vidnovlennia rukhovykh funktsii pislia perenesenoho mozkovoho insultu. Klinichna ta profilaktychna medytsyna. 2020; 4(14):33-43. DOI: 10.31612/2616-4868.4(14).2020.02 [Ukrainian]
16. Gage M, Phillips K, Noh B, Yoon T. Effect of an Alpha-GPC Supplement on Physical Performance in Division 2 Football Players. Medicine & Science in Sports & Exercise. 2017; 49(5S):942. DOI: 10.1249/01.mss.0000519566.89731.74
17. Nasonova TI, Kolosova TV, Slobodyn TM, Klymenko OV, Kurochkin IV, Riabychenko TM, ta in. Porushennia pamiati y uvahy v patsiientiv serednoho viku: diahnostyka y likuvannia. Mizhnarodnyi nevrolohichnyi zhurnal. 2018; 2(96):19-25. DOI: 10.22141/2224-0713.2.96.2018.130478 [Ukrainian]
18. Bellar D, LeBlanc N, Campbell B. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of the International Society of Sports Nutrition. 2015; 12:42. DOI 10.1186/s12970-015-0103-x
19. Mishchenko TS. Mishchenko VN. Lapshina IA. Gliatilin v lechenii postinsultnykh bolnykh. Mezhdunarodnyy nevrologicheskiy zhurnal. 2016; 4(82):25-31 [Russian]
20. Traini E, Bramanti V, Amenta F. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent. Current Alzheimer research. 2013; 10(10):1070-1079. DOI: 10.2174/15672050113106660173
Published
2021-08-31
How to Cite
Пушко, О., & Литвиненко, Н. (2021). ЗАСТОСУВАННЯ Α-ГЛІЦЕРИЛФОСФОРИЛХОЛІНУ В СХЕМІ КОМПЛЕКСНОГО ЛІКУВАННЯ ДЛЯ ФУНКЦІОНАЛЬНОГО ВІДНОВЛЕННЯ ПІСЛЯ МОЗКОВОГО ПІВКУЛЬОВОГО ІШЕМІЧНОГО ІНСУЛЬТУ. The Medical and Ecological Problems, 25(3-4), 8-13. https://doi.org/10.31718/mep.2021.25.3-4.02